Roche is set to strengthen its breast cancer franchise with the acquisition of privately-held Seragon Pharmaceuticals Inc of San Diego, California. Seragon has new technology for treating estrogen-driven cancers. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
